IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.888
EU - Europa 3.776
AS - Asia 1.162
OC - Oceania 9
AF - Africa 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.844
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.870
IE - Irlanda 1.027
SE - Svezia 1.007
CN - Cina 649
IT - Italia 591
SG - Singapore 407
UA - Ucraina 296
DE - Germania 248
PL - Polonia 175
FI - Finlandia 164
GB - Regno Unito 97
FR - Francia 68
IN - India 55
BE - Belgio 40
RU - Federazione Russa 18
CA - Canada 17
NL - Olanda 17
VN - Vietnam 14
IR - Iran 12
CZ - Repubblica Ceca 9
AU - Australia 7
ID - Indonesia 7
JP - Giappone 6
AT - Austria 5
KR - Corea 4
EC - Ecuador 3
EG - Egitto 3
ES - Italia 3
LU - Lussemburgo 3
RO - Romania 3
CH - Svizzera 2
HK - Hong Kong 2
IL - Israele 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
EU - Europa 1
GE - Georgia 1
KH - Cambogia 1
MX - Messico 1
NG - Nigeria 1
PH - Filippine 1
TR - Turchia 1
Totale 8.844
Salva come PNG Salva come JPEG
Città #
Dublin 1.027
Chandler 736
Jacksonville 642
Nyköping 513
Singapore 330
Beijing 288
Ashburn 216
Messina 182
Warsaw 174
Princeton 170
Boardman 162
Cambridge 157
Medford 153
Dearborn 144
Ann Arbor 139
Des Moines 127
Jinan 56
Woodbridge 53
Wilmington 44
Shenyang 40
Brussels 37
Los Angeles 33
San Mateo 33
Catania 31
Bremen 30
Hyderabad 28
Lancaster 28
Zhengzhou 27
Hebei 26
New York 23
Ningbo 21
Helsinki 18
Nanjing 18
Haikou 17
Houston 17
Taizhou 17
Pune 16
Seattle 16
Tianjin 16
Rome 15
Dong Ket 14
Munich 14
Guangzhou 13
Washington 13
Lanzhou 11
Norwalk 11
Hefei 10
Nanchang 10
Ottawa 10
Viagrande 10
Caltagirone 9
Milan 9
Brno 8
Hangzhou 8
Ardabil 7
Changsha 7
Falls Church 7
Jakarta 7
Trecastagni 7
Auburn Hills 6
Bari 6
Clearwater 6
Jiaxing 5
London 5
Naples 5
Taiyuan 5
Augusta 4
Fuzhou 4
Leawood 4
Monmouth Junction 4
Mountain View 4
Scandicci 4
Turin 4
Bologna 3
Capoterra 3
Clifton 3
Florence 3
Kemerovo 3
Luxembourg 3
Mascalucia 3
Modling 3
Mumbai 3
New Delhi 3
Paterno 3
Polverigi 3
Pompei 3
Quito 3
Redmond 3
Rho 3
Riva 3
San Costanzo 3
San Filippo 3
Toronto 3
Vittoria 3
Waanrode 3
Acireale 2
Amsterdam 2
Andover 2
Boston 2
Brisbane 2
Totale 6.147
Salva come PNG Salva come JPEG
Nome #
Inositolo e sindrome metabolica in menopausa 194
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 113
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 108
Italian risk factor-based screening for gestational diabetes. 99
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 88
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 88
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 88
Effects of myo-inositol on glucose variability in women with gestational diabetes 88
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 85
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 83
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 83
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 80
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 79
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 79
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 79
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 78
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 78
Compliance with hormone replacement therapy in postmenopausal Sicilian women 75
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 74
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 73
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 73
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 73
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 72
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 72
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 72
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 71
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 71
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 69
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 69
ADAM 12 come marker precoce di preeclampsia 69
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 69
Dietary management of skin health: The role of genistein 68
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 67
Myo-inositol and melatonin in the menopausal transition 67
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 66
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 65
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 65
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 64
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 63
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 63
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 63
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 63
Rupture of the cervix in a sulprostone induced abortion in the second trimester 62
Cardiovascular effects of raloxifene hydrochloride 62
Cardiovascular effects of the phytoestrogen genistein 62
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 62
Myo-inositol may prevent gestational diabetes in PCOS women 62
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 62
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 62
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 61
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 61
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 61
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 61
Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials 61
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 61
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 60
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 60
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 60
THE PHYTOESTROGEN GENISTEIN PHYSIOLOGICALLY IMPROVES BONE AND CARDIOVASCULAR FUNCTIONALITY IN POSTMENOPAUSAL WOMEN 60
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 60
C-reactive protein as an early predictor of gestational diabetes mellitus 59
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 59
Dalla soia nuove speranze per la gestione della sindrome metabolica 59
Midtrimester amniotic fluid adiponectin in normal pregnancy. 58
The impact of kidney development on the life course: a consensus document for action 58
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 57
Genistein aglycone use in metabolic syndrome: preliminary results from a randomized clinical trial in postmenopausal women 57
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology - assisted reproduction technology 57
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 56
Neurokinin B peptide levels in normal pregnancy 56
Large placental chorioangioma 56
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 56
Urinary excretion of aquaporin-2 water channel during pregnancy 55
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 55
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 54
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a randomized, double-blind, placebo-controlled study 54
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 54
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 54
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 54
Positive effects of the phytoestrogen genistein on bone metabolism in postmenopausal women 53
La disfunzione diastolica nel diabete gestazionale 53
Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal 53
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 53
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 52
GENISTEIN AGLYCONE: A DUAL MODE OF ACTION ANTI-OSTEOPOROTIC SOY ISOFLAVONE REBALANCING BONE TURNOVER TOWARDS BONE FORMATION 52
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 52
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 52
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 52
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 51
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 51
Maternal serum PAPP-A as an early marker of obstetric complications? 51
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 51
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 50
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 50
PREGNANCY IN THE OBESE PATIENT 49
Positive effects of the isoflavone genistein on cardiovascular system in osteopenic, postmenopausal women 49
Endothelin-1 production in umbilical arteries from hypertensive pregnant women 49
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 49
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 49
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction 48
Totale 6.543
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020997 0 0 0 0 13 140 174 134 51 234 212 39
2020/20211.266 127 30 263 73 91 120 90 128 73 138 79 54
2021/20221.216 11 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/2025505 68 29 70 221 117 0 0 0 0 0 0 0
Totale 9.105